- Home
- GIPR vs SCNX Comparison
GIPR vs SCNX Comparison
Compare GIPR & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GIPR | SCNX |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Other Pharmaceuticals |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 24.8M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GIPR | SCNX |
|---|---|---|
| Price | $0.75 | $0.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 731.3K | ★ 1.7M |
| Earning Date | 11-17-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,953,920.00 | $653,391.00 |
| Revenue This Year | $1.12 | N/A |
| Revenue Next Year | $0.52 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 207.88 |
| 52 Week Low | $0.73 | $0.46 |
| 52 Week High | $2.06 | $8.19 |
Technical Indicators
Market Signals| Indicator | GIPR | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 36.32 | 42.76 |
| Support Level | $0.80 | $0.49 |
| Resistance Level | $1.34 | $0.60 |
| Average True Range (ATR) | 0.13 | 0.06 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 3.93 | 15.46 |
Price Performance
Historical ComparisonAbout GIPR Generation Income Properties Inc.
Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.